Gov't already planning approval of antiviral drug Avigan in Nov.

The Japanese government is already planning to approve the antiviral drug Avigan as a COVID-19 treatment in November even before its developer has filed for regulatory review, government sources said Saturday.Under that plan, the review of the influenza drug Avigan as a new coronavirus treatment will be completed in an unprecedentedly short screening period of three weeks once Fujifilm Toyama Chemical Co. submits a new drug application, expected in mid-October, the sources said, raising concerns about whether its safety and efficacy will be thoroughly scrutinized.Despite some concerns about th…

Read More

HEDGE accordingly